La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Receptors, Dopamine (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Dopamine (genetics) < Receptors, Dopamine (metabolism) < Receptors, Dopamine (physiology)  Facettes :

List of bibliographic references indexed by Receptors, Dopamine (metabolism)

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000262 (2016) Julieta E. Arena [Canada] ; A Jon Stoessl [Canada]Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
000A29 (2014) Nicolas Morin [Canada] ; Thérèse Di Paolo [Canada]Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease.
000A70 (2014) Amaal Al Dakheel [Canada] ; Isabelle Beaulieu-Boire ; Susan H. FoxEmerging drugs for levodopa-induced dyskinesia.
000F54 (2013) Ji Hyun Ko [Canada] ; Francesca Antonelli [Canada] ; Oury Monchi [Canada] ; Nicola Ray [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Leigh Christopher [Canada] ; Antonio P. Strafella [Canada]Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease
002975 (2005) J M Brotchie [Canada] ; J. Lee ; K. VenderovaLevodopa-induced dyskinesia in Parkinson's disease.
002D86 (2003) A Jon Stoessl [Canada] ; Raúl De La Fuente-FernándezDopamine receptors in Parkinson's disease: imaging studies.
002E98 (2003) Pierre J. Blanchet [Canada]The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects
002F18 (2003) A. Hadj Tahar [Canada] ; R. Grondin [Canada] ; L. Gregoire [Canada] ; F. Calon [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada]New insights in Parkinson's disease therapy: Can levodopa-induced dyskinesia ever be manageable
003109 (2001) C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O PoulterRegeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
003308 (2001) M. Guttman [Canada] ; D. Stewart [Canada] ; D. Hussey [Canada] ; A. Wilson [Canada] ; S. Houle [Canada] ; S. Kish [Canada]Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD
003800 (1999) M. Ichise [Canada] ; Y. J. Kim [Canada] ; J. R. Ballinger [Canada] ; D. Vines [Canada] ; S. S. Erami [Canada] ; F. Tanaka [Canada] ; A. E. Lang [Canada]SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD
003801 (1999) D. E. Hobson [Canada] ; E. Pourcher [Canada] ; W. R. W. Martin [Canada]Ropinirole and pramipexole, the new agonists
004392 (1993) Philip Seeman [Canada] ; Hong-Chang Guan [Canada] ; Hubert H. M. Van Tol [Canada] ; Hyman B. Niznik [Canada]Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata
004650 (1992) M. Guttman [Canada]Dopamine receptors in Parkinson's disease
004855 (1990) P. Seeman [Canada] ; H B NiznikDopamine receptors and transporters in Parkinson's disease and schizophrenia.
004A14 (1989) P. Seeman ; H B Niznik ; H C Guan ; G. Booth ; C. UlpianLink between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
004B89 (1988) Mohamed N. Hassan [Canada] ; Jay H. Thakar [Canada]Dopamine receptors in Parkinson's disease
004C61 (1988) P. Falardeau ; S. Bouchard ; P. J. Bedard ; R. Boucher ; T. Di PaoloBehavioral and biochemical effect of chronic treatment with D-1 and/or D-2dopamine agonists in MPTP monkeys
004C77 (1987) P. Seeman [Canada] ; N H Bzowej ; H C Guan ; C. Bergeron ; G P Reynolds ; E D Bird ; P. Riederer ; K. Jellinger ; W W TourtellotteHuman brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
004C87 (1987) M. Beaulieu [Canada]Clinical importance of D-1 and D-2 receptors.
005659 (????) K. Mizukawa [Canada] ; E G Mcgeer ; P L McgeerAutoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Receptors, Dopamine (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Receptors, Dopamine (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Receptors, Dopamine (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022